Impact of anakinra use on clinical outcomes in children with moderate or severe multisystem inflammatory syndrome in children: a propensity score matched retrospective cohort study

BACKGROUND: The treatment of children with multisystem inflammatory syndrome in children (MIS-C) related to SARS-CoV-2 infection involves immunomodulatory therapies such as IVIG and steroids. Anakinra, an interleukin-1 receptor inhibitor, has also been used, but its effectiveness is not established...

Descripción completa

Detalles Bibliográficos
Autores principales: Akkoyun, Esra B., Most, Zachary, Katragadda, Harita, Yu, Andrew, Nassi, Lorien, Oakman, Nicole, Ginsburg, Sarah, Maamari, Mia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666339/
https://www.ncbi.nlm.nih.gov/pubmed/37996856
http://dx.doi.org/10.1186/s12969-023-00924-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666339/
https://www.ncbi.nlm.nih.gov/pubmed/37996856
http://dx.doi.org/10.1186/s12969-023-00924-6

Ejemplares similares